• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Next Generation Sequencing Market 2012-2016 - Product Image

Global Next Generation Sequencing Market 2012-2016

  • Published: September 2013
  • Region: Global
  • 117 Pages
  • TechNavio

FEATURED COMPANIES

  • 23andMe Inc.
  • Axeq Technologies Inc.
  • Foundation Medicine Inc.
  • Good Start Genetics Inc.
  • Illumina Inc.
  • Life Technologies Corp.
  • MORE

The analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market.

The report, Global Next Generation Sequencing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc.

The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics READ MORE >

01. Executive Summary
02. Scope of the Report
02.1 Market Overview
02.2 Product Offerings
03. Market Research Methodology
03.1 Market Research Process
03.2 Research Design
03.3 Research Methodology
04. List of Abbreviations
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Next Generation Sequencing Market in the US
06.3.1 Market Size and Forecast
06.4 Next Generation Sequencing Market in Europe
06.4.1 Market Size and Forecast
06.4.2 Top Five Next Generation Sequencing Instruments in Europe
06.5 Next Generation Sequencing Market in Japan
06.5.1 Market Size and Forecast
06.6 Five Forces Analysis
07. Market Segmentation by Application
08. Market Segmentation by Technology
08.1.1 Sequencing by Synthesis
08.1.2 Ion Semiconductor Sequencing
08.1.3 Sequencing by Ligation
08.1.4 Pyrosequencing
08.1.5 SMRT Sequencing
08.2 Comparison of Various Technologies
09. Market Segmentation by Product
09.1 Global Next Generation Sequencing Market by Product Snapshot
09.2 Global Next Generation Sequencing Market by Reagents
09.2.1 Market Size and Forecast
09.3 Global Next Generation Sequencing Market by Instruments
09.3.1 Market Size and Forecast
09.3.2 Price of Next Generation Instruments
09.3.3 Market Segmentation
09.4 Global Next Generation Sequencing Market by Services
09.4.1 Market Size and Forecast
09.5 Global Next Generation Sequencing Market by Product 2012-2016 (in percentage)
09.6 Global Next Generation Sequencing Market by Product Growth Rate
10. Market Segmentation by End-users
10.1 Global Next Generation Sequencing Market by End-users Snapshot
10.2 Global Next Generation Sequencing Market by Academia
10.2.1 Market Size and Forecast
10.3 Global Next Generation Sequencing Market by Biopharma
10.3.1 Market Size and Forecast
10.4 Global Next Generation Sequencing Market by Applied Markets
10.4.1 Market Size and Forecast
10.5 Global Next Generation Sequencing Market by Clinical Customers
10.5.1 Market Size and Forecast
10.6 Global Next Generation Sequencing Market by End-users Growth Rate
11. Geographical Segmentation
11.1 Global Next Generation Sequencing Market by Geographical Segmentation 2012-2016
11.2 Global Next Generation Sequencing Market by Geographical Segmentation Snapshot
11.3 Next Generation Sequencing Market in the Americas
11.3.1 Market Size and Forecast
11.4 Next Generation Sequencing Market in the EMEA Region
11.4.1 Market Size and Forecast
11.5 Next Generation Sequencing Market in the APAC Region
11.5.1 Market Size and Forecast
11.6 Global Next Generation Sequencing Market by Geographical Segmentation 2012-2016
12. Key Leading Countries
12.1 USA
12.2 UK
12.3 Japan
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2012
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 Beijing Genome Institute
21.1.1 Business Overview
21.1.2 Business Segmentation
21.1.3 Key Information
21.1.4 SWOT Analysis
21.2 Illumina Inc.
21.2.1 Business Overview
21.2.2 Business Segmentation
21.2.3 Specifications and Costs of Roche Platforms and Associated Reagents
21.2.4 Key Information
21.2.5 SWOT Analysis
21.3 Life Technologies Corp.
21.3.1 Business overview
21.3.2 Business Segmentation
21.3.3 Specifications and Costs of Life Technologies Platforms and Associated Reagents
21.3.4 Key Information
21.3.5 SWOT Analysis
21.4 Pacific Biosciences of California Inc.
21.4.1 Business Overview
21.4.2 Business Segmentation
21.4.3 Key Information
21.4.4 SWOT Analysis
21.5 QIAGEN N.V.
21.5.1 Business Overview
21.5.2 Business Segmentation
21.5.3 Key Information
21.5.4 SWOT Analysis
21.6 Roche Holding Ltd.
21.6.1 Business Overview
21.6.2 Business Segmentation
21.6.3 Specifications and Costs of Roche Platforms and Associated Reagents
21.6.4 Key Information
21.6.5 SWOT Analysis
22. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Next Generation Sequencing Market Segmentation
Exhibit 3: Global Genomics Market Segmentation
Exhibit 4: Global Genomics Market Segmentation
Exhibit 5: Global Next Generation Sequencing Market 2012-2016 (US$ million)
Exhibit 6: Next Generation Sequencing Market in the US 2012-2016 (US$ million)
Exhibit 7: Next Generation Sequencing Market in Europe 2012-2016 (US$ million)
Exhibit 8: Next Generation Sequencing Market in Japan 2012-2016 (US$ million)
Exhibit 9: Global Next Generation Sequencing Market Segmentation by Application
Exhibit 10: Global Next Generation Sequencing Market Segmentation by Technology
Exhibit 11: Global Next Generation Sequencing Market Segmentation by Product
Exhibit 12: Global Next Generation Sequencing Market Segmentation by Product 2012
Exhibit 13: Global Next Generation Sequencing Market by Reagents 2012-2016 (US$ million)
Exhibit 14: Global Next Generation Sequencing Market by Instruments 2012-2016 (US$ million)
Exhibit 15: Global Next Generation Sequencing Market by Instruments Segmentation
Exhibit 16: Global Next Generation Sequencing Market by Instruments Segmentation 2012
Exhibit 17: Global Next Generation Sequencing Market by Services 2012-2016 (US$ million)
Exhibit 18: Global Next Generation Sequencing Market by Product 2012-2016 (in percentage)
Exhibit 19: Global Next Generation Sequencing Market by Product Growth Rate
Exhibit 20: Global Next Generation Sequencing Market Segmentation by End-users
Exhibit 21: Global Next Generation Sequencing Market Segmentation by End-users 2012
Exhibit 22: Global Next Generation Sequencing Market by Academia 2012-2016 (US$ million)
Exhibit 23: Global Next Generation Sequencing Market by Biopharma 2012-2016 (US$ million)
Exhibit 24: Global Next Generation Sequencing Market by Applied Markets 2012-2016 (US$ million)
Exhibit 25: Global Next Generation Sequencing Market by Clinical Customers 2012-2016 (US$ million)
Exhibit 26: Global Next Generation Sequencing Market by End-users Growth Rate 2012
Exhibit 27: Global Next Generation Sequencing Market by Geographical Segmentation 2012
Exhibit 28: Global Next Generation Sequencing Market in the Americas 2012-2016 (US$ million)
Exhibit 29: Global Next Generation Sequencing Market in the EMEA Region 2012-2016 (US$ million)
Exhibit 30: Global Next Generation Sequencing Market in the APAC Region 2012-2016 (US$ million)
Exhibit 31: Global Next Generation Sequencing Market by Geographical Segmentation 2012-2016 (in percentage)
Exhibit 32: Global Next Generation Sequencing Market by Vendor Segmentation 2012
Exhibit 33: Business Segmentation of Beijing Genomic Institute
Exhibit 34: Business Segmentation of Illumina Inc.
Exhibit 35: Business Segmentation of Life Technologies Corp.
Exhibit 36: Business Segmentation of Pacific Biosciences of California Inc.
Exhibit 37: Business Segmentation of QIAGEN N.V.
Exhibit 38: Business Segmentation of Roche Holding Ltd.

Commenting on the report, an analyst from the team said: “With the expansion of the customer base to less sophisticated customers, access to improved bioinformatics tools is becoming even more of a priority. Sequencing companies started to seriously tackle this issue: in 2012 Life Technologies unveiled Ion Reporter, a commercial cloud-based variant analysis software package and purchased Compendia Bioscience. Illumina launched BaseSpace Apps, a dedicated application store for BaseSpace, its genomics cloud computing platform. In addition, Illumina secured the buy-in of bioinformatics companies such as Golden Helix, Biomatters, Ingenuity, Station X, and Spiral Genetics, on top of collaborations with Diagnomics, Ingenuity, and Knome.”

According to the report, the growth of the Global Next-generation Sequencing market is driven by several factors, the most important of which is the increased adoption of next-generation sequencing technology by new customers.

Further, the report states that one of the key challenges in the market is the low adoption of genomic technology compared to other sequence analysis technologies, especially among large biotechnology companies. This is mainly because of logistical problems such as instrument complexity, problems in data storage, automation, and sample preparation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

- 23andMe Inc.
- Ambry Genetics Corp.
- Axeq Technologies Inc.
- Beijing Genomics Institute
- Fluidigm Corp.
- Foundation Medicine Inc.
- GeneDx
- Good Start Genetics Inc.
- Helicos BioSciences Corp.
- Illumina Inc.
- Knome Inc.
- Life Technologies Corp.
- NABsys Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California Inc.
- Pathogenica Inc.
- QIAGEN N.V
- RainDance Technologies Inc.
- Roche Holding AG
- Sequenom Inc.
- Takara Bio Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos